| 633438 |
JOURNAL OF MID-LIFE HEALTH |
Endometrium at menopause: The pathologist's view |
2021-01-01 |
10.4103/jmh.jmh_218_21 |
Swain Meenakshi, Kulkarni AdityaD |
| 633437 |
JOURNAL OF EPIDEMIOLOGY : OFFICIAL JOURNAL OF THE JAPAN EPIDEMIOLOGICAL ASSOCIATION |
Lower respiratory tract infections and orofacial clefts: a prospective cohort study from the Japan Environment and Children’s Study |
2021-01-01 |
10.2188/jea.je20200438 |
Sato Yukihiro, Yoshioka Eiji, Saijo Yasuaki, Miyamoto Toshinobu, Azuma Hiroshi, Tanahashi Yusuke, Ito Yoshiya, Kobayashi Sumitaka, Minatoya Machiko, Ait Bamai Yu, Yamazaki Keiko, Ito Sachiko, Miyashita Chihiro, Araki Atsuko, Kishi Reiko, The Japan Environment and Children’s Study (JECS) Group |
| 633436 |
JOURNAL OF CANCER |
EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells |
2021-01-01 |
10.7150/jca.48310 |
Xu Linyan, Gao Xiang, Yang Pu, Sang Wei, Jiao Jun, Niu Mingshan, Liu Mengdi, Qin Yuanyuan, Yan Dongmei, Song Xuguang, Sun Cai, Tian Yu, Zhu Feng, Sun Xiaoshen, Zeng Lingyu, Li Zhenyu, Xu Kailin |
| 633435 |
JOURNAL OF CANCER |
Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients |
2021-01-01 |
10.7150/jca.51413 |
Li Ming, Xu Xiao, Qin Yingyi, Zhang Peng, Shen Changxing, Xia Qing, Fan Lihong |
| 633434 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells |
2021-01-01 |
10.1016/j.biopha.2020.111055 |
Merckaert Tijs, Zwaenepoel Olivier, Gevaert Kris, Gettemans Jan |
| 633433 |
JOURNAL OF CANCER |
Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma |
2021-01-01 |
10.7150/jca.59273 |
Liu Yi, Xu Yichi, Jiang Mengying, Chen Weinan, Zhu Xueqiong |
| 633432 |
BMJ OPEN |
Acupuncture for biliary colic: a systematic review protocol |
2021-01-01 |
10.1136/bmjopen-2020-041931 |
Sun Ning, Zuo Wenwei, Zhou Yuanfang, Cheng Ying, Cheng Shirui, Zhou Jun, Xu Guixing, Huang Liuyang, Liang Fanrong, Sun Ruirui |
| 633431 |
CLINICAL LUNG CANCER |
A Phase I/II study of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer |
2021-01-01 |
10.1016/j.cllc.2020.09.016 |
Tanaka Hisashi, Hasegawa Yukihiro, Makiguchi Tomonori, Okumura Fumihiko, Tabe Chiori, Shiratori Toshihiro, Ishioka Yoshiko, Itoga Masamichi, Taima Kageaki, Yokouchi Junichi, Hatayama Yoshiomi, Aoki Masahiko, Tasaka Sadatomo |
| 633430 |
THERANOSTICS |
Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy |
2021-01-01 |
10.7150/thno.45777 |
Cai Shuxian, Chen Ziyi, Wang Yingjie, Wang Min, Wu Junye, Tong Yuhong, Chen Lanlan, Lu Chunhua, Yang Huanghao |
| 633429 |
THERANOSTICS |
Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance |
2021-01-01 |
10.7150/thno.59342 |
Wei Xiao, Song Mingzhu, Li Weijie, Huang Jing, Yang Guang, Wang Yi |
